Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Ameliorative Role of Diabetes Remission in Aging: A Real-World-Based Prospective Clinical Cohort Study

Authors not listed

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2026

Abstract

This study is a real-world, prospective clinical cohort study. It will enroll Chinese patients with type 2 diabetes. The aim is to assess the changes in aging biomarkers, primarily DunedinPACE, from baseline to post-remission, and to compare these biomarkers between patients who achieve successful remission and those who do not.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-31 MST

Cite this

APA
Anonymous. (2026). The Ameliorative Role of Diabetes Remission in Aging: A Real-World-Based Prospective Clinical Cohort Study. <em>Second Affiliated Hospital, Zhejiang University, School of Medicine</em>. https://clinicaltrials.gov/study/NCT07736040
Vancouver
Anonymous. The Ameliorative Role of Diabetes Remission in Aging: A Real-World-Based Prospective Clinical Cohort Study. Second Affiliated Hospital, Zhejiang University, School of Medicine. 2026.
BibTeX
@misc{anon2026TheAme, title = {The Ameliorative Role of Diabetes Remission in Aging: A Real-World-Based Prospective Clinical Cohort Study}, author = {Anonymous}, journal = {Second Affiliated Hospital, Zhejiang University, School of Medicine}, year = {2026}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings